ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Obesity Diagnosis and Treatment Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-39L17631
Home | Market Reports | Beauty & Fitness| Weight Loss
Global Obesity Diagnosis and Treatment Market Research Report 2024
BUY CHAPTERS

Global Obesity Diagnosis and Treatment Market Research Report 2024

Code: QYRE-Auto-39L17631
Report
July 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Pfizer Inc
GlaxoSmithKline PLC
Arena Pharmaceuticals
Allergan plc
Obalon Therapeutics
Nalpropion Pharmaceuticals
Novo Nordisk
Beijing Noble Laser Technology
Eisai Co Ltd
Orexigen Therapeutics
ReShape Lifesciences
Roche
Allurion Technologies
Medtronic Inc
VIVUS
ApolloEndosurgery
Ethicon Inc
Astrazeneca plc
Takeda Pharmaceutical Company
Currax Pharmaceuticals
Obesity diagnosis and treatment

Obesity Diagnosis and Treatment Market

The global Obesity Diagnosis and Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Obesity Diagnosis and Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Obesity Diagnosis and Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Obesity Diagnosis and Treatment in <18 Years Old is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Obesity Diagnosis and Treatment include Obesity diagnosis and treatment, GlaxoSmithKline, Arena Pharmaceuticals, Pfizer, Allergan, Obalon Therapeutics, Nalpropion Pharmaceuticals, Novo Nordisk, Beijing Noble Laser Technology, Eisai, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Obesity Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Diagnosis and Treatment.
The Obesity Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Obesity Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Obesity Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Obesity Diagnosis and Treatment Market Report

Report Metric Details
Report Name Obesity Diagnosis and Treatment Market
Segment by Type
  • Medication
  • Surgery
  • Fitness
  • Others
Segment by Application
  • <18 Years Old
  • 18-35 Years Old
  • 36-45 Years Old
  • 45-55 Years Old
  • >55 Years Old
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Obesity diagnosis and treatment, GlaxoSmithKline, Arena Pharmaceuticals, Pfizer, Allergan, Obalon Therapeutics, Nalpropion Pharmaceuticals, Novo Nordisk, Beijing Noble Laser Technology, Eisai, Orexigen Therapeutics, ReShape Lifesciences, Roche, Allurion Technologies, Medtronic, VIVUS, ApolloEndosurgery, Ethicon, Inc., AstraZeneca, Takeda Pharmaceutical Company, Currax Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Obesity Diagnosis and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Obesity Diagnosis and Treatment Market report?

Ans: The main players in the Obesity Diagnosis and Treatment Market are Obesity diagnosis and treatment, GlaxoSmithKline, Arena Pharmaceuticals, Pfizer, Allergan, Obalon Therapeutics, Nalpropion Pharmaceuticals, Novo Nordisk, Beijing Noble Laser Technology, Eisai, Orexigen Therapeutics, ReShape Lifesciences, Roche, Allurion Technologies, Medtronic, VIVUS, ApolloEndosurgery, Ethicon, Inc., AstraZeneca, Takeda Pharmaceutical Company, Currax Pharmaceuticals

What are the Application segmentation covered in the Obesity Diagnosis and Treatment Market report?

Ans: The Applications covered in the Obesity Diagnosis and Treatment Market report are <18 Years Old, 18-35 Years Old, 36-45 Years Old, 45-55 Years Old, >55 Years Old

What are the Type segmentation covered in the Obesity Diagnosis and Treatment Market report?

Ans: The Types covered in the Obesity Diagnosis and Treatment Market report are Medication, Surgery, Fitness, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obesity Diagnosis and Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medication
1.2.3 Surgery
1.2.4 Fitness
1.2.5 Others
1.3 Market by Application
1.3.1 Global Obesity Diagnosis and Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 <18 Years Old
1.3.3 18-35 Years Old
1.3.4 36-45 Years Old
1.3.5 45-55 Years Old
1.3.6 >55 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Obesity Diagnosis and Treatment Market Perspective (2019-2030)
2.2 Global Obesity Diagnosis and Treatment Growth Trends by Region
2.2.1 Global Obesity Diagnosis and Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Obesity Diagnosis and Treatment Historic Market Size by Region (2019-2024)
2.2.3 Obesity Diagnosis and Treatment Forecasted Market Size by Region (2025-2030)
2.3 Obesity Diagnosis and Treatment Market Dynamics
2.3.1 Obesity Diagnosis and Treatment Industry Trends
2.3.2 Obesity Diagnosis and Treatment Market Drivers
2.3.3 Obesity Diagnosis and Treatment Market Challenges
2.3.4 Obesity Diagnosis and Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Obesity Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Obesity Diagnosis and Treatment Players by Revenue (2019-2024)
3.1.2 Global Obesity Diagnosis and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Obesity Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Obesity Diagnosis and Treatment Revenue
3.4 Global Obesity Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Obesity Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obesity Diagnosis and Treatment Revenue in 2023
3.5 Global Key Players of Obesity Diagnosis and Treatment Head office and Area Served
3.6 Global Key Players of Obesity Diagnosis and Treatment, Product and Application
3.7 Global Key Players of Obesity Diagnosis and Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Obesity Diagnosis and Treatment Breakdown Data by Type
4.1 Global Obesity Diagnosis and Treatment Historic Market Size by Type (2019-2024)
4.2 Global Obesity Diagnosis and Treatment Forecasted Market Size by Type (2025-2030)
5 Obesity Diagnosis and Treatment Breakdown Data by Application
5.1 Global Obesity Diagnosis and Treatment Historic Market Size by Application (2019-2024)
5.2 Global Obesity Diagnosis and Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Obesity Diagnosis and Treatment Market Size (2019-2030)
6.2 North America Obesity Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Obesity Diagnosis and Treatment Market Size by Country (2019-2024)
6.4 North America Obesity Diagnosis and Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Obesity Diagnosis and Treatment Market Size (2019-2030)
7.2 Europe Obesity Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Obesity Diagnosis and Treatment Market Size by Country (2019-2024)
7.4 Europe Obesity Diagnosis and Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Obesity Diagnosis and Treatment Market Size (2019-2030)
8.2 Asia-Pacific Obesity Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Obesity Diagnosis and Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Obesity Diagnosis and Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Obesity Diagnosis and Treatment Market Size (2019-2030)
9.2 Latin America Obesity Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Obesity Diagnosis and Treatment Market Size by Country (2019-2024)
9.4 Latin America Obesity Diagnosis and Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Obesity Diagnosis and Treatment Market Size (2019-2030)
10.2 Middle East & Africa Obesity Diagnosis and Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Obesity Diagnosis and Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Obesity Diagnosis and Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Obesity diagnosis and treatment
11.1.1 Obesity diagnosis and treatment Company Details
11.1.2 Obesity diagnosis and treatment Business Overview
11.1.3 Obesity diagnosis and treatment Obesity Diagnosis and Treatment Introduction
11.1.4 Obesity diagnosis and treatment Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.1.5 Obesity diagnosis and treatment Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Obesity Diagnosis and Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Details
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Obesity Diagnosis and Treatment Introduction
11.3.4 Arena Pharmaceuticals Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.3.5 Arena Pharmaceuticals Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Obesity Diagnosis and Treatment Introduction
11.4.4 Pfizer Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Obesity Diagnosis and Treatment Introduction
11.5.4 Allergan Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.5.5 Allergan Recent Development
11.6 Obalon Therapeutics
11.6.1 Obalon Therapeutics Company Details
11.6.2 Obalon Therapeutics Business Overview
11.6.3 Obalon Therapeutics Obesity Diagnosis and Treatment Introduction
11.6.4 Obalon Therapeutics Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.6.5 Obalon Therapeutics Recent Development
11.7 Nalpropion Pharmaceuticals
11.7.1 Nalpropion Pharmaceuticals Company Details
11.7.2 Nalpropion Pharmaceuticals Business Overview
11.7.3 Nalpropion Pharmaceuticals Obesity Diagnosis and Treatment Introduction
11.7.4 Nalpropion Pharmaceuticals Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.7.5 Nalpropion Pharmaceuticals Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Details
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Obesity Diagnosis and Treatment Introduction
11.8.4 Novo Nordisk Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.8.5 Novo Nordisk Recent Development
11.9 Beijing Noble Laser Technology
11.9.1 Beijing Noble Laser Technology Company Details
11.9.2 Beijing Noble Laser Technology Business Overview
11.9.3 Beijing Noble Laser Technology Obesity Diagnosis and Treatment Introduction
11.9.4 Beijing Noble Laser Technology Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.9.5 Beijing Noble Laser Technology Recent Development
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Obesity Diagnosis and Treatment Introduction
11.10.4 Eisai Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.10.5 Eisai Recent Development
11.11 Orexigen Therapeutics
11.11.1 Orexigen Therapeutics Company Details
11.11.2 Orexigen Therapeutics Business Overview
11.11.3 Orexigen Therapeutics Obesity Diagnosis and Treatment Introduction
11.11.4 Orexigen Therapeutics Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.11.5 Orexigen Therapeutics Recent Development
11.12 ReShape Lifesciences
11.12.1 ReShape Lifesciences Company Details
11.12.2 ReShape Lifesciences Business Overview
11.12.3 ReShape Lifesciences Obesity Diagnosis and Treatment Introduction
11.12.4 ReShape Lifesciences Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.12.5 ReShape Lifesciences Recent Development
11.13 Roche
11.13.1 Roche Company Details
11.13.2 Roche Business Overview
11.13.3 Roche Obesity Diagnosis and Treatment Introduction
11.13.4 Roche Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.13.5 Roche Recent Development
11.14 Allurion Technologies
11.14.1 Allurion Technologies Company Details
11.14.2 Allurion Technologies Business Overview
11.14.3 Allurion Technologies Obesity Diagnosis and Treatment Introduction
11.14.4 Allurion Technologies Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.14.5 Allurion Technologies Recent Development
11.15 Medtronic
11.15.1 Medtronic Company Details
11.15.2 Medtronic Business Overview
11.15.3 Medtronic Obesity Diagnosis and Treatment Introduction
11.15.4 Medtronic Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.15.5 Medtronic Recent Development
11.16 VIVUS
11.16.1 VIVUS Company Details
11.16.2 VIVUS Business Overview
11.16.3 VIVUS Obesity Diagnosis and Treatment Introduction
11.16.4 VIVUS Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.16.5 VIVUS Recent Development
11.17 ApolloEndosurgery
11.17.1 ApolloEndosurgery Company Details
11.17.2 ApolloEndosurgery Business Overview
11.17.3 ApolloEndosurgery Obesity Diagnosis and Treatment Introduction
11.17.4 ApolloEndosurgery Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.17.5 ApolloEndosurgery Recent Development
11.18 Ethicon, Inc.
11.18.1 Ethicon, Inc. Company Details
11.18.2 Ethicon, Inc. Business Overview
11.18.3 Ethicon, Inc. Obesity Diagnosis and Treatment Introduction
11.18.4 Ethicon, Inc. Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.18.5 Ethicon, Inc. Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Details
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Obesity Diagnosis and Treatment Introduction
11.19.4 AstraZeneca Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.19.5 AstraZeneca Recent Development
11.20 Takeda Pharmaceutical Company
11.20.1 Takeda Pharmaceutical Company Company Details
11.20.2 Takeda Pharmaceutical Company Business Overview
11.20.3 Takeda Pharmaceutical Company Obesity Diagnosis and Treatment Introduction
11.20.4 Takeda Pharmaceutical Company Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.20.5 Takeda Pharmaceutical Company Recent Development
11.21 Currax Pharmaceuticals
11.21.1 Currax Pharmaceuticals Company Details
11.21.2 Currax Pharmaceuticals Business Overview
11.21.3 Currax Pharmaceuticals Obesity Diagnosis and Treatment Introduction
11.21.4 Currax Pharmaceuticals Revenue in Obesity Diagnosis and Treatment Business (2019-2024)
11.21.5 Currax Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Pfizer Inc
GlaxoSmithKline PLC
Arena Pharmaceuticals
Allergan plc
Obalon Therapeutics
Nalpropion Pharmaceuticals
Novo Nordisk
Beijing Noble Laser Technology
Eisai Co Ltd
Orexigen Therapeutics
ReShape Lifesciences
Roche
Allurion Technologies
Medtronic Inc
VIVUS
ApolloEndosurgery
Ethicon Inc
Astrazeneca plc
Takeda Pharmaceutical Company
Currax Pharmaceuticals
Obesity diagnosis and treatment
List of Tables
 Table 1. Global Obesity Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Medication
 Table 3. Key Players of Surgery
 Table 4. Key Players of Fitness
 Table 5. Key Players of Others
 Table 6. Global Obesity Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Obesity Diagnosis and Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Obesity Diagnosis and Treatment Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Obesity Diagnosis and Treatment Market Share by Region (2019-2024)
 Table 10. Global Obesity Diagnosis and Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Obesity Diagnosis and Treatment Market Share by Region (2025-2030)
 Table 12. Obesity Diagnosis and Treatment Market Trends
 Table 13. Obesity Diagnosis and Treatment Market Drivers
 Table 14. Obesity Diagnosis and Treatment Market Challenges
 Table 15. Obesity Diagnosis and Treatment Market Restraints
 Table 16. Global Obesity Diagnosis and Treatment Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Obesity Diagnosis and Treatment Market Share by Players (2019-2024)
 Table 18. Global Top Obesity Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Diagnosis and Treatment as of 2023)
 Table 19. Ranking of Global Top Obesity Diagnosis and Treatment Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Obesity Diagnosis and Treatment Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Obesity Diagnosis and Treatment, Headquarters and Area Served
 Table 22. Global Key Players of Obesity Diagnosis and Treatment, Product and Application
 Table 23. Global Key Players of Obesity Diagnosis and Treatment, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Obesity Diagnosis and Treatment Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Obesity Diagnosis and Treatment Revenue Market Share by Type (2019-2024)
 Table 27. Global Obesity Diagnosis and Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Obesity Diagnosis and Treatment Revenue Market Share by Type (2025-2030)
 Table 29. Global Obesity Diagnosis and Treatment Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Obesity Diagnosis and Treatment Revenue Market Share by Application (2019-2024)
 Table 31. Global Obesity Diagnosis and Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Obesity Diagnosis and Treatment Revenue Market Share by Application (2025-2030)
 Table 33. North America Obesity Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Obesity Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Obesity Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Obesity Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Obesity Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Obesity Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Obesity Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Obesity Diagnosis and Treatment Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Obesity Diagnosis and Treatment Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Obesity Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Obesity Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Obesity Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Obesity Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Obesity Diagnosis and Treatment Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Obesity Diagnosis and Treatment Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Obesity diagnosis and treatment Company Details
 Table 49. Obesity diagnosis and treatment Business Overview
 Table 50. Obesity diagnosis and treatment Obesity Diagnosis and Treatment Product
 Table 51. Obesity diagnosis and treatment Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 52. Obesity diagnosis and treatment Recent Development
 Table 53. GlaxoSmithKline Company Details
 Table 54. GlaxoSmithKline Business Overview
 Table 55. GlaxoSmithKline Obesity Diagnosis and Treatment Product
 Table 56. GlaxoSmithKline Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 57. GlaxoSmithKline Recent Development
 Table 58. Arena Pharmaceuticals Company Details
 Table 59. Arena Pharmaceuticals Business Overview
 Table 60. Arena Pharmaceuticals Obesity Diagnosis and Treatment Product
 Table 61. Arena Pharmaceuticals Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 62. Arena Pharmaceuticals Recent Development
 Table 63. Pfizer Company Details
 Table 64. Pfizer Business Overview
 Table 65. Pfizer Obesity Diagnosis and Treatment Product
 Table 66. Pfizer Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 67. Pfizer Recent Development
 Table 68. Allergan Company Details
 Table 69. Allergan Business Overview
 Table 70. Allergan Obesity Diagnosis and Treatment Product
 Table 71. Allergan Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 72. Allergan Recent Development
 Table 73. Obalon Therapeutics Company Details
 Table 74. Obalon Therapeutics Business Overview
 Table 75. Obalon Therapeutics Obesity Diagnosis and Treatment Product
 Table 76. Obalon Therapeutics Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 77. Obalon Therapeutics Recent Development
 Table 78. Nalpropion Pharmaceuticals Company Details
 Table 79. Nalpropion Pharmaceuticals Business Overview
 Table 80. Nalpropion Pharmaceuticals Obesity Diagnosis and Treatment Product
 Table 81. Nalpropion Pharmaceuticals Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 82. Nalpropion Pharmaceuticals Recent Development
 Table 83. Novo Nordisk Company Details
 Table 84. Novo Nordisk Business Overview
 Table 85. Novo Nordisk Obesity Diagnosis and Treatment Product
 Table 86. Novo Nordisk Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 87. Novo Nordisk Recent Development
 Table 88. Beijing Noble Laser Technology Company Details
 Table 89. Beijing Noble Laser Technology Business Overview
 Table 90. Beijing Noble Laser Technology Obesity Diagnosis and Treatment Product
 Table 91. Beijing Noble Laser Technology Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 92. Beijing Noble Laser Technology Recent Development
 Table 93. Eisai Company Details
 Table 94. Eisai Business Overview
 Table 95. Eisai Obesity Diagnosis and Treatment Product
 Table 96. Eisai Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 97. Eisai Recent Development
 Table 98. Orexigen Therapeutics Company Details
 Table 99. Orexigen Therapeutics Business Overview
 Table 100. Orexigen Therapeutics Obesity Diagnosis and Treatment Product
 Table 101. Orexigen Therapeutics Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 102. Orexigen Therapeutics Recent Development
 Table 103. ReShape Lifesciences Company Details
 Table 104. ReShape Lifesciences Business Overview
 Table 105. ReShape Lifesciences Obesity Diagnosis and Treatment Product
 Table 106. ReShape Lifesciences Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 107. ReShape Lifesciences Recent Development
 Table 108. Roche Company Details
 Table 109. Roche Business Overview
 Table 110. Roche Obesity Diagnosis and Treatment Product
 Table 111. Roche Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 112. Roche Recent Development
 Table 113. Allurion Technologies Company Details
 Table 114. Allurion Technologies Business Overview
 Table 115. Allurion Technologies Obesity Diagnosis and Treatment Product
 Table 116. Allurion Technologies Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 117. Allurion Technologies Recent Development
 Table 118. Medtronic Company Details
 Table 119. Medtronic Business Overview
 Table 120. Medtronic Obesity Diagnosis and Treatment Product
 Table 121. Medtronic Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 122. Medtronic Recent Development
 Table 123. VIVUS Company Details
 Table 124. VIVUS Business Overview
 Table 125. VIVUS Obesity Diagnosis and Treatment Product
 Table 126. VIVUS Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 127. VIVUS Recent Development
 Table 128. ApolloEndosurgery Company Details
 Table 129. ApolloEndosurgery Business Overview
 Table 130. ApolloEndosurgery Obesity Diagnosis and Treatment Product
 Table 131. ApolloEndosurgery Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 132. ApolloEndosurgery Recent Development
 Table 133. Ethicon, Inc. Company Details
 Table 134. Ethicon, Inc. Business Overview
 Table 135. Ethicon, Inc. Obesity Diagnosis and Treatment Product
 Table 136. Ethicon, Inc. Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 137. Ethicon, Inc. Recent Development
 Table 138. AstraZeneca Company Details
 Table 139. AstraZeneca Business Overview
 Table 140. AstraZeneca Obesity Diagnosis and Treatment Product
 Table 141. AstraZeneca Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 142. AstraZeneca Recent Development
 Table 143. Takeda Pharmaceutical Company Company Details
 Table 144. Takeda Pharmaceutical Company Business Overview
 Table 145. Takeda Pharmaceutical Company Obesity Diagnosis and Treatment Product
 Table 146. Takeda Pharmaceutical Company Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 147. Takeda Pharmaceutical Company Recent Development
 Table 148. Currax Pharmaceuticals Company Details
 Table 149. Currax Pharmaceuticals Business Overview
 Table 150. Currax Pharmaceuticals Obesity Diagnosis and Treatment Product
 Table 151. Currax Pharmaceuticals Revenue in Obesity Diagnosis and Treatment Business (2019-2024) & (US$ Million)
 Table 152. Currax Pharmaceuticals Recent Development
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Obesity Diagnosis and Treatment Picture
 Figure 2. Global Obesity Diagnosis and Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Obesity Diagnosis and Treatment Market Share by Type: 2023 VS 2030
 Figure 4. Medication Features
 Figure 5. Surgery Features
 Figure 6. Fitness Features
 Figure 7. Others Features
 Figure 8. Global Obesity Diagnosis and Treatment Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Obesity Diagnosis and Treatment Market Share by Application: 2023 VS 2030
 Figure 10. <18 Years Old Case Studies
 Figure 11. 18-35 Years Old Case Studies
 Figure 12. 36-45 Years Old Case Studies
 Figure 13. 45-55 Years Old Case Studies
 Figure 14. >55 Years Old Case Studies
 Figure 15. Obesity Diagnosis and Treatment Report Years Considered
 Figure 16. Global Obesity Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 17. Global Obesity Diagnosis and Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 18. Global Obesity Diagnosis and Treatment Market Share by Region: 2023 VS 2030
 Figure 19. Global Obesity Diagnosis and Treatment Market Share by Players in 2023
 Figure 20. Global Top Obesity Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Diagnosis and Treatment as of 2023)
 Figure 21. The Top 10 and 5 Players Market Share by Obesity Diagnosis and Treatment Revenue in 2023
 Figure 22. North America Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. North America Obesity Diagnosis and Treatment Market Share by Country (2019-2030)
 Figure 24. United States Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Canada Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Europe Obesity Diagnosis and Treatment Market Share by Country (2019-2030)
 Figure 28. Germany Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. France Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. U.K. Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Italy Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Russia Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Nordic Countries Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Asia-Pacific Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Asia-Pacific Obesity Diagnosis and Treatment Market Share by Region (2019-2030)
 Figure 36. China Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Japan Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. South Korea Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. India Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Australia Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Latin America Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Latin America Obesity Diagnosis and Treatment Market Share by Country (2019-2030)
 Figure 44. Mexico Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Brazil Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East & Africa Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Middle East & Africa Obesity Diagnosis and Treatment Market Share by Country (2019-2030)
 Figure 48. Turkey Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. UAE Obesity Diagnosis and Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Obesity diagnosis and treatment Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 52. GlaxoSmithKline Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 53. Arena Pharmaceuticals Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 54. Pfizer Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 55. Allergan Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 56. Obalon Therapeutics Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 57. Nalpropion Pharmaceuticals Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 58. Novo Nordisk Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 59. Beijing Noble Laser Technology Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 60. Eisai Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 61. Orexigen Therapeutics Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 62. ReShape Lifesciences Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 63. Roche Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 64. Allurion Technologies Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 65. Medtronic Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 66. VIVUS Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 67. ApolloEndosurgery Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 68. Ethicon, Inc. Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 69. AstraZeneca Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 70. Takeda Pharmaceutical Company Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 71. Currax Pharmaceuticals Revenue Growth Rate in Obesity Diagnosis and Treatment Business (2019-2024)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Anti obesity Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Food Allergy Diagnosis Treatment Market Insights Forecast to 2030
Global Overweight patient Bed Market Research Report 2024
Anti Obesity Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Disease Treatment Market Research Report 2024
Global Overweight patient Care System Market Research Report 2024
Obesity Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Obesity Treatment Surgery Devices Market Insights Forecast to 2030
Global Prescription Diet Market Research Report 2024
Pediatric Obesity Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attention Deficit Hyperactivity Disorder Treatment Market Research Report 2024
Weight Loss and Weight Management Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Obesity Treatment Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Overweight patient Lift Market Research Report 2024
Global Overweight patient Scales Market Research Report 2024
Global Weight Loss and Diet Management Market Research Report 2025
Bed for the Obese Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Obese Patient Surgery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiometabolic Disease Drug Market Research Report 2024
Global Meal Replacement for Dieting Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions